Managing osteonecrosis of the jaw

Dr Marx speaks with ecancer at NOSCM 2017 to discuss osteonecrosis of the jaw.
He outlines the cancer drugs linked to disease onset, and gives the perspective of facial/dental surgeons in minimising adverse events and promoting therapy adherence.
In terms of managing infection, Dr Marx recommends penicillin-based antibiotics or anthracyclines, and in the case of advanced disease he describes how surgical interventions can preserve appearance and quality of life.